Sign in
CompletedNo phase

Gender-based Differences in the Outcome of the Treatment of Persistent Septic Shock With Hydrocortisone

Key facts

Who runs it
Alexandria University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
621 people enrolled
Started
1 Jan 2023
Ended
1 Aug 2024
Type of study
Observational, 2 groups
Record updated
6 August 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (2)Hide the full registry criteria

Who can take part

  • Adult patients of both sexes with persistent septic shock received hydrocortisone during their intensive care unit (ICU) stay

Who cannot take part

  • Patients with incomplete data sets

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to explore the gender-based differences in the outcomes of treatment with hydrocortisone in critically ill patients with persistent septic shock.

The 2 groups in the trial

  • The Female Group

    Patients are categorized as females according to their apparent gender.

  • The Male Group

    Patients are categorized as males according to their apparent gender.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
6 August 2024